PAHO Director calls for country ownership and regional solidarity in reshaping global health architecture - Pan American Health Organization (PAHO)
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Berlin, 15 October 2026 (PAHO) – Pan American Health Organization (PAHO) Director and WHO Regional Director for the Americas Dr. Jarbas Barbosa called for countries and regional institutions to have a stronger role in shaping ongoing reforms of the global health system during the World Health Summit 2026 in Berlin this week, arguing that clearer responsibilities across national, regional and global levels can reduce duplication and help limited health resources deliver greater impact. His call comes as WHO Member States and global health partners are examining how health cooperation is governed, financed and delivered amid tighter financial conditions and concerns over fragmentation and duplication. The reform process is considering how responsibilities, coordination and financing should be aligned across country, regional and global levels, with final recommendations expected to be considered by the World Health Assembly in 2027. Drawing on the experience of the Americas, Dr. Barbosa highlighted how regional cooperation can bridge global health commitments and action within countries.
This article is an excerpt. To read the full content, visit the original source. Pan American Health Organization (PAHO)
Related articles
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!